Immune Control's Series A Round

Immune Control raised a round of funding on July 13, 2005.

Immune Control is an early-stage drug discovery company that has developed novel approaches to immune modulation using small molecule, serotonin antagonists. Merged with Arginetix to form Corridor …

Articles about Immune Control's Series A Round: